The findings in the present study implied that WNT5A-driven EMT might be the cause of poorer patient survival in NPC patients because the co-elevated expression of WNT5A and vimentin correlated with shorter disease-free and relapse-free survival times. The gene discussed is WNT5A; the disease is nasopharyngeal carcinoma.